Skarpelos Athanasios

Avg. Two Year Performance

(30%) Avg. Purchase Return
(14%) Compound
(23%) Avg. Sale Return
(11%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return4%29%50%(1%)(30%)
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return(5%)(38%)(7%)(64%)(23%)
Sale Success Rate0 of 31 of 31 of 30 of 32 of 3
Drugs » Biotechnology

Director:

Holdings: 1.31M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--